Priti Patel serves as Executive at Neoleukin Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Priti Patel has executed 6 insider transactions totaling $18.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 3, 2023 involved selling 3,769 shares valued at $2.6K.
Priti Patel currently holds 37,313 shares of Neoleukin Therapeutics, Inc. (NLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Priti Patel has been a net seller of NLTX stock. They have purchased $0 and sold $18.0K worth of shares.
Priti Patel's most recent insider trade was on Apr 3, 2023, when they sold 3,769 shares at $0.69 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 2, 2023 | NLTX | $8.6K | Sale | 14,380 | $0.60 | Discretionary |
| Feb 1, 2023 | NLTX | $0 | Option Exercise | 35,000 | $N/A | Discretionary |
| May 2, 2022 | NLTX | $6.8K | Sale | 5,538 | $1.22 | Discretionary |
| Apr 30, 2022 | NLTX | $0 | Option Exercise | 10,000 | $N/A | Discretionary |